Soluble TREM2 Is Elevated in Pediatric Patients with Anti-NMDAR Encephalitis

Anna Zhou1, Changhong Ren1, Ji Zhou1

  • 1Department of Neurology, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China.

PubMed

Insights

Soluble Triggering Receptor Expressed on Myeloid cells 2 (sTREM2) in cerebrospinal fluid (CSF) is a promising biomarker for diagnosing and predicting outcomes in pediatric anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. Higher CSF sTREM2 levels indicate greater neuroinflammation and poorer prognosis.

Area of Science:

  • Neuroimmunology
  • Biomarker Discovery
  • Pediatric Neurology

Background:

  • Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a severe autoimmune neurological disorder in children.
  • Accurate diagnostic and prognostic biomarkers are critical for effective management of pediatric anti-NMDAR encephalitis.
  • Soluble Triggering Receptor Expressed on Myeloid cells 2 (sTREM2) is being investigated for its role in neuroinflammation.

Purpose of the Study:

  • To evaluate soluble Triggering Receptor Expressed on Myeloid cells 2 (sTREM2) in cerebrospinal fluid (CSF) and serum as diagnostic and prognostic biomarkers in pediatric anti-NMDAR encephalitis.
  • To assess the correlation between sTREM2 levels and disease severity and outcomes.

Main Methods:

  • The study involved 21 pediatric patients with anti-NMDAR encephalitis and 27 controls with non-inflammatory neurological disorders (OND).
  • CSF and serum samples were analyzed for sTREM2 levels using enzyme-linked immunosorbent assay (ELISA).
  • Statistical analyses included Mann-Whitney U test and ROC curve analysis to determine diagnostic and prognostic value.

Main Results:

  • Children with anti-NMDAR encephalitis exhibited significantly higher CSF and serum sTREM2 levels compared to controls (p < 0.001).
  • CSF sTREM2 levels positively correlated with disease severity (mRS scores) and negatively with neurological function (GCS scores).
  • CSF sTREM2 demonstrated high diagnostic accuracy (AUC = 0.887), with serum sTREM2 also showing significant accuracy (AUC = 0.848).
  • Lower CSF sTREM2 levels were associated with better patient prognoses (p = 0.029).

Conclusions:

  • Elevated CSF sTREM2 levels are linked to increased neuroinflammation and adverse clinical outcomes in pediatric anti-NMDAR encephalitis.
  • CSF sTREM2 shows potential as a valuable biomarker for diagnosing pediatric anti-NMDAR encephalitis.
  • sTREM2 may aid in predicting prognosis and guiding treatment strategies for affected children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
279
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
247
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
311
Factors Affecting Solubility04:01

Factors Affecting Solubility

Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Chȃtelier’s principle. Consider the dissolution of silver iodide:
37.3K
Solubility Equilibria03:07

Solubility Equilibria

Solubility equilibria are established when the dissolution and precipitation of a solute species occur at equal rates. These equilibria underlie many natural and technological processes, ranging from tooth decay to water purification. An understanding of the factors affecting compound solubility is, therefore, essential to the effective management of these processes. This section applies previously introduced equilibrium concepts and tools to systems involving dissolution and precipitation.
The...
57.9K